
Omez Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Omeprazole (40mg)
Overview Omez Injection
Gastric acid secretion is reduced by the intravenous medication, Omez Injection. This proton pump inhibitor (PPI) treats stomach and intestinal disorders stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It alleviates symptoms and facilitates healing. Administered intravenously by a medical professional, Omez Injection is also utilized to prevent stress ulcers in critically ill patients and pre-anesthetically to mitigate aspiration risks. Its suitability as an injection, rather than oral administration, will be determined by your physician based on your individual needs. Dosage and treatment length are personalized, but consistent adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Dietary modifications, such as consuming smaller, more frequent meals and avoiding caffeine, spicy, and fatty foods, can enhance treatment efficacy. Common, generally mild, side effects include nausea, headache, gas, diarrhea, abdominal discomfort, and injection site reactions (pain, swelling, redness). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year or with higher dosages, increases bone fracture risk. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Omez Injection is contraindicated for individuals with severe liver impairment, prior allergic reactions to similar medications, or pre-existing osteoporosis. Inform your physician of all concurrent medications, especially those for HIV, fungal infections, tuberculosis, epilepsy, or anticoagulants, due to potential interactions. Pregnant or breastfeeding individuals should seek medical counsel before use. Alcohol consumption should be avoided as it stimulates gastric acid production and may exacerbate symptoms. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Uses of Omez Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Omez Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Omez Injection:
- Injection site reactions (pain, swelling, redness)
- Diarrhea
- Flatulence
- Headache
- Nausea
- Vomiting
- Abdominal pain
How to use Omez Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Omez Injection works:
Omez Injection, a proton pump inhibitor, decreases stomach acid production, providing relief from acid-related gastrointestinal disorders including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while using Omez Injection.
PregnancySAFE IF PRESCRIBED
Employing Omez Injection during pregnancy is considered safe. The preponderance of research indicates minimal or negligible risk to the fetus.
Breast feedingSAFE IF PRESCRIBED
Administering Omez Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Omez Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Patients with renal impairment can safely receive Omez Injection without requiring any modification to the prescribed dosage.
LiverCAUTION
Patients with severe hepatic impairment should use Omez Injection cautiously, potentially requiring dosage modification. Physician consultation is recommended. Reduced dosages may be appropriate for patients with liver disease on long-term Omez Injection therapy.
What if you forget to take Omez Injection :
Should you forget a scheduled Omez Injection, seek your physician's advice.
Facts to Know About Omez Injection
| Label | Value |
|---|---|
| Chemical Type | Timolol Derivative |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
